This spectacular figure was propelled by the record-shattering second quarter, and a record seven deals over $100M.
Five deals were over $50 million, including PatientsLikeMe, Livongo Health, Alignment Healthcare, Nuna Health and Evariant.
The market has experienced an uptick with 13% TTM growth and almost 50% YoY growth (when compared to Q1 2015); it was also the highest Q1 since 2011.
Rock Health argues that digital biomarkers can extend the collection of population level health data and introduce longitudinal data for individual consumers.
Having a balanced number of men and women on leadership teams allows for a diversified set of opinions and perspectives that impact a company's bottom line.
2015 was a record year for industry consolidation, with M&A activity nearly doubling in volume -- there were 180 deals and $6 billion in disclosed activity.
Under the deal, Rock Health will fund and support digital startups, while Boston Children's will act as clinical advisor to the promising companies.
Respondents were most likely to search for physician (44%) and hospital (33%) reviews, followed by nursing homes (10%) and professional caregivers (7%).
At $15.8 million, the average deal size is the largest yet, although deal count is down 9% compared to last year (when looking at US deals over $2M).
With these deals, CVS is looking to collaborate with the most advanced and capable organizations to develop future-looking healthcare solutions.